Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Gazzard

Showing results (31-40 of 206) with videos related to

Pageof 21
Sort By:
AIDS (London, England)|November 21, 2007
Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experienceLaura J Waters, Sundhiya Mandalia, Brian Gazzard, et al.
AIDS (London, England)|October 9, 2002
The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patientsAlan Winston, Sundhiya Mandalia, Deenan Pillay, et al.
Sexually Transmitted Infections|February 21, 2012
Maintaining cost-effective access to antiretroviral drug therapy through a collaborative approach to drug procurement, consensus treatment guidelines and regular audit: the experience of London HIV commissioners and providersClaire Foreman, Brian Gazzard, Margaret Johnson, et al.
AIDS (London, England)|July 1, 2011
Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavirNeesha Rockwood, Sundhiya Mandalia, Mark Bower, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirsAntonio Pires, Gareth Hardy, Brian Gazzard, et al.
AIDS (London, England)|March 28, 2003
Leptomeningeal disease in AIDS-related non-Hodgkin's lymphomaDebashish Sarker, Christina Thirlwell, Mark Nelson, et al.
Lancet (London, England)|April 5, 2011
Increasing burden of liver disease in patients with HIV infectionDeepak Joshi, John O'Grady, Doug Dieterich, et al.
Antiviral Therapy|September 9, 2011
The value of screening HIV-infected individuals for didanosine-related liver disease?Andrew Scourfield, Akil Jackson, Laura Waters, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2006
Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicityKatrina Pollock, Justin Stebbing, Mark Bower, et al.
The Journal of Infectious Diseases|May 8, 2009
Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10Sandrine Buisson, Adel Benlahrech, Brian Gazzard, et al.
Pageof 21

Showing results (31-40 of 206) with videos related to

Sort By:
Pageof 21
AIDS (London, England)|November 21, 2007
Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experienceLaura J Waters, Sundhiya Mandalia, Brian Gazzard, et al.
AIDS (London, England)|October 9, 2002
The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patientsAlan Winston, Sundhiya Mandalia, Deenan Pillay, et al.
Sexually Transmitted Infections|February 21, 2012
Maintaining cost-effective access to antiretroviral drug therapy through a collaborative approach to drug procurement, consensus treatment guidelines and regular audit: the experience of London HIV commissioners and providersClaire Foreman, Brian Gazzard, Margaret Johnson, et al.
AIDS (London, England)|July 1, 2011
Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavirNeesha Rockwood, Sundhiya Mandalia, Mark Bower, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirsAntonio Pires, Gareth Hardy, Brian Gazzard, et al.
AIDS (London, England)|March 28, 2003
Leptomeningeal disease in AIDS-related non-Hodgkin's lymphomaDebashish Sarker, Christina Thirlwell, Mark Nelson, et al.
Lancet (London, England)|April 5, 2011
Increasing burden of liver disease in patients with HIV infectionDeepak Joshi, John O'Grady, Doug Dieterich, et al.
Antiviral Therapy|September 9, 2011
The value of screening HIV-infected individuals for didanosine-related liver disease?Andrew Scourfield, Akil Jackson, Laura Waters, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2006
Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicityKatrina Pollock, Justin Stebbing, Mark Bower, et al.
The Journal of Infectious Diseases|May 8, 2009
Monocyte-derived dendritic cells from HIV type 1-infected individuals show reduced ability to stimulate T cells and have altered production of interleukin (IL)-12 and IL-10Sandrine Buisson, Adel Benlahrech, Brian Gazzard, et al.
Pageof 21